Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Pre-eclampsia has emerged as a notifiable cause of maternal and fetal morbidity and mortality (94)
If you meet the eligibility criteriaeither a BMI of 30 or higher or a BMI of 25 to 29.9 in addition to a health conditionand youre struggling to lose weight postpartum while implementing lifestyle changes, you could be a candidate for GLP-1s
In a randomized controlled trial, tirzepatide at doses of 10 mg and 15 mg resulted in an average weight reduction of 20% and 21%, respectively, while the 5 mg dose led to a 15% weight loss, compared to 3% with placebo
For many people, the challenge is not just getting started
The strategy could help Novo Nordisk compete against upcoming generic alternatives expected to launch this summer
Big Potential
